Allosteric activation mechanism of the type VII CRISPR-Cas system
Nucleic Acids Research · 19.03.2026 · 54 (6)
DOI: 10.1093/nar/gkag314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 08.04.2026. Verfasst von Shuqin Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Medical University Cancer Institute and Hospital, State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment …. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, CRISPR-Associated Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Tianjin Municipal Science and Technology Commission, Tianjin Key Medical Discipline (Specialty) Construction Project.
Abstract (Originalsprache)
Type VII CRISPR-Cas system, evolutionarily associated with type III systems, utilizes a Cascade complex formed by Cas5 and catalytically inactive Cas7 copies for target RNA binding, but instead incorporates a specialized Cas14 ribonuclease for target cleavage. Here, we report a high-quality cryo-EM structure at the target engagement state with a shortened crRNA and elucidate how the recruited Cas14 captures the target RNA and undergoes target-mediated activation. The signature Cas14 is homologous to eukaryotic CPSF73 and prokaryotic RNase J, comprising two conserved subdomains, MβL and β-CASP. Different from canonical type III systems, 5′-end target RNA, rather than 3′-end, is bent into the positively charged binding channel formed by the two subdomains to access the conserved catalytic pocket on Cas14. Two special structural features, α1 helix from Cas7 and α10 helix from Cas14, promote the bent target RNA docking into the catalytic pocket of Cas14 nuclease in concert. A dual-functional loop, displaced by the entering target RNA, induces a closed-to-open transition between the two subdomains for nuclease activation. More importantly, the flipped dual-functional loop also maintains the stabilization of incoming target RNA. Altogether, our work provides a more comprehensive understanding of type VII system mechanism, laying a mechanistic foundation for RNA-targeting tool development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Tianjin Medical University Cancer Institute and Hospital, State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Ministry Co-spon…
- Tianjin Key Laboratory of Cellular Homeostasis and Disease, Key Laboratory of Cancer Prevention and Therapy, Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin 300070, China.
- Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center…
- Department of Pharmacology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
- Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Cent…
ORCID-Profile: Heng Zhang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Tianjin Municipal Science and Technology Commission
- Tianjin Key Medical Discipline (Specialty) Construction Project
Zitieren
APA
Zhang, S., Liu, Y., Wu, W., Liu, Z., He, Q., Wang, T., Yang, J., Yin, H., Yuan, Z., & Zhang, H. (2026). Allosteric activation mechanism of the type VII CRISPR-Cas system. Nucleic Acids Research, 54(6). https://doi.org/10.1093/nar/gkag314
Vancouver
Zhang S, Liu Y, Wu W, Liu Z, He Q, Wang T, et al. Allosteric activation mechanism of the type VII CRISPR-Cas system. Nucleic Acids Research. 2026;54(6). doi:10.1093/nar/gkag314
BibTeX
@article{Zhang2026,
author = {Zhang, Shuqin and Liu, Yingcan and Wu, Wenqi and Liu, Zhikun and He, Qiuqiu and Wang, Tongyao and Yang, Jie and Yin, Hang and Yuan, Zhiyong and Zhang, Heng},
title = {Allosteric activation mechanism of the type VII CRISPR-Cas system},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {6},
doi = {10.1093/nar/gkag314}
}
EUVIMED